|
|
Effects of Etidronate Disodium on Bone Mineral Density and Bone Turnover Indexes in Elderly Osteoporosis Patients |
Yu Kai, Li Hualong, Cheng Shenjie, Su Jianmin |
Department of Orthopaedics,Zhengzhou First People's Hospital,Zhengzhou 450000,China |
|
|
Abstract Objective To study clinical effect and value of etidronate disodium(ED) in treatment of elderly osteoporosis patients.Methods A total of 160 elderly osteoporosis patients who were admitted were randomly grouped according to different clinical treatment schemes,80 cases in each group.The patients treated with D-calfor were included in control group,while patients treated with ED and D-calfor were included in experimental group.BMD scores and clinical response rates in both groups were observed and validated.Results The data statistics showed that clinical response rates in experimental group was significantly higher than that in control group(96.25% vs 86.25%)(P<0.05).After treatment,there were significant differences in BMD score between experimental group and control group[(0.48±0.03) points vs(0.46±0.02) points](P<0.05).After treatment,there were significant differences in BMD score in experimental group before and after treatment [(0.46±0.08) vs(0.48±0.03) points](P<0.05).Conclusion The curative effect of ED is significant on elderly osteoporosis patients.
|
Received: 01 March 2020
|
|
|
|
|
[1] 熊慧丽,赵晓宏,周庆元,等.依替膦酸二钠对老年性骨质疏松症的疗效及安全性分析[J].现代生物医学进展,2017,17(18):3532-3535. [2] 白玉,程慧,周锋涛,等.强骨胶囊对老年性骨质疏松症患者骨密度及骨转换生化指标的影响[J].风湿病与关节炎,2016,5(3):22-24. [3] 栾霞,王学宏,邢翠珍,等.鲑鱼降钙素联合海滨疗养因子对老年性骨质疏松症骨密度和骨转换指标影响的研究[J].中国骨质疏松杂志,2016,22(6):741-745. [4] 汤红志. 阿伦膦酸钠对改善老年T2DM并骨质疏松患者骨密度、骨转换指标的影响研究[J].医药卫生:全文版,2017(2):111-113. [5] 王芳,任汉强,沈晓波.胰岛素联合阿仑膦酸钠对老年糖尿病骨质疏松症患者骨密度及血清BAP、TRAP-5b、BGP水平影响[J].海南医学院学报,2016,22(13):1387-1389. [6] 徐灵芝,鲍艳芳,何斐,等.鲑鱼降钙素鼻喷剂对绝经后骨质疏松患者骨密度及骨转换指标的影响[J].中国基层医药,2017,24(2):174-177. |
[1] |
Liu Minmin, Chen Rijin, Lv Weidong, Liao Cairong, Huang Zi. The Effect of Calcium Carbonate D3 Granules on Improving Bone Mineral Density in Children with Nutritional Rickets and Its Adverse Reactions[J]. journal1, 2021, 41(2): 1-2. |
[2] |
. [J]. journal1, 2021, 41(1): 45-45. |
[3] |
. [J]. journal1, 2021, 41(1): 46-47. |
|
|
|
|